Castelli Jeff
Chief Development Officer
Castelli Jeff has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Apr 27, 2026.
On the most recent filing, Castelli Jeff is listed as Chief Development Officer at AMICUS THERAPEUTICS, INC. Inside the rolling window, Castelli Jeff reported no open-market purchases and 1 open-market sale totaling $774K in FOLD.
Companies traded
Other insiders at FOLD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$774K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Castelli Jeff made?
Castelli Jeff has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Castelli Jeff trade?
Castelli Jeff has filed SEC Form 4 disclosures for 1 company, including FOLD.
When was Castelli Jeff's most recent SEC Form 4 filing?
Castelli Jeff's most recent SEC Form 4 filing on Tracefour is dated Apr 27, 2026.
What is Castelli Jeff's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Castelli Jeff is listed as Chief Development Officer.
What is Castelli Jeff's total buy and sell value in the current window?
Inside the rolling retention window, Castelli Jeff bought $0 and sold $774K based on SEC Form 4 filings.
What was Castelli Jeff's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 76,158 FOLD shares on 2025-11-24, worth $774K, per SEC Form 4 filings.